IP Library Granted Patent US 9,504,740
Granted Patent B2
US 9,504,740 · App. 14/507,397 · Granted Nov 29, 2016

Patent

Inventors: Paulraj Kirubakaran Lawrence (Worthington, MN); Russell F. Bey (Arden Hills, MN)
Assignee: MERIAL, INC.
A61K39/102A61K2039/521A61K2039/552A61K2039/70
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,504,740
App. No.
14/507,397
Granted
Nov 29, 2016
Kind
B2
Abstract

The present invention is a Haemophilus parasuis vaccine against serovar type 4 capable of triggering a protective immune response when administered to pigs as a killed vaccine. The present invention is also a method for vaccinating swine against Haemophilus parasuis infection, serovar type 4, by a) clonally propagating one or more cells which are capable of triggering an immune response against Haemophilus parasuis infection, serovar type 4, that protects the pig against Haemophilus parasuis infection, and b) combining an immunologically effective amount of the cells with a veterinarily acceptable carrier in a form suitable for administration as a vaccine to the pig, and c) administering as a killed vaccine. The cell culture is from a pathogenic parent strain.

Claims (11)

1. A vaccine for Haemophilus parasuis, serovar type 4, comprising a veterinarily acceptable carrier and an immunologically effective amount of killed bacterin or bacterial cell culture capable of triggering an immune response that protects swine against Haemophilus parasuis infection;

wherein the DNA sequence of the bacterin or bacterial cell culture comprises SEQ ID NO: 2; and

wherein the killed bacterin or bacterial cell culture is chemically inactivated.

2. A vaccine for Haemophilus parasuis, serovar type 4, comprising a veterinarily acceptable carrier and an immunologically effective amount of killed bacterin or bacterial cell culture capable of triggering an immune response that protects swine against Haemophilus parasuis infection, wherein the DNA sequence of the bacterin or bacterial cell culture comprises SEQ ID NO: 3; and

wherein the killed bacterin or bacterial cell culture is chemically inactivated.

3. The vaccine of claim 1 , further comprising the vaccine against Haemophilus parasuis, serovar type 5 according to SEQ ID NO: 1.

4. The vaccine of claim 2 , further comprising the vaccine against Haemophilus parasuis, serovar type 5 according to SEQ ID NO: 1.

5. A method for vaccinating swine against Haemophilus parasuis infection, serovar type 4, comprising the step of administering the vaccine of claim 1 .

6. A method for vaccinating swine against Haemophilus parasuis infection, serovar type 4, comprising the step of administering the vaccine of claim 2 .

7. A method for vaccinating swine against Haemophilus parasuis infection, serovar type 4, comprising the step of administering the vaccine of claim 3 .

8. A method for vaccinating swine against Haemophilus parasuis infection, serovar type 4, comprising the step of administering the vaccine of claim 4 .

Assignments (6)
CHANGE OF NAME Recorded Feb 2, 2024
From: NEWPORT LABORATORIES, INC.
To: VAXXINOVA US, INC.
Reel/Frame 066335/0274 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2021
From: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
To: NEWPORT LABORATORIES, INC.
Reel/Frame 057726/0859 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2021
From: MERIAL, INC.
To: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Reel/Frame 056151/0032 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2016
From: MERIAL LIMITED
To: MERIAL, INC.
Reel/Frame 038571/0333 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2016
From: MERIAL LIMITED
To: MERIAL, INC.
Reel/Frame 038481/0457 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2015
From: LAWRENCE, PAULRAJ KIRUBAKARAN; BEY, RUSSELL F.
To: MERIAL LIMITED
Reel/Frame 035167/0922 →
Continuity (2)
Provisional Application 61886991 · Oct 4, 2013
Related Publication 20150098968A1 · Apr 9, 2015